Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of ARS 302.95 trillion. The enterprise value is 336.86 trillion.
Market Cap | 302.95T |
Enterprise Value | 336.86T |
Important Dates
The next estimated earnings date is Thursday, July 17, 2025.
Earnings Date | Jul 17, 2025 |
Ex-Dividend Date | Mar 12, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -2.90% |
Shares Change (QoQ) | -1.25% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.87B |
Valuation Ratios
The trailing PE ratio is 21.95 and the forward PE ratio is 14.48.
PE Ratio | 21.95 |
Forward PE | 14.48 |
PS Ratio | 5.30 |
PB Ratio | 7.34 |
P/TBV Ratio | n/a |
P/FCF Ratio | 16.03 |
P/OCF Ratio | 14.86 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.77, with an EV/FCF ratio of 17.83.
EV / Earnings | 24.41 |
EV / Sales | 4.52 |
EV / EBITDA | 10.77 |
EV / EBIT | 13.56 |
EV / FCF | 17.83 |
Financial Position
The company has a current ratio of 0.79, with a Debt / Equity ratio of 0.81.
Current Ratio | 0.79 |
Quick Ratio | 0.50 |
Debt / Equity | 0.81 |
Debt / EBITDA | 1.40 |
Debt / FCF | 1.78 |
Interest Coverage | 16.83 |
Financial Efficiency
Return on equity (ROE) is 32.89% and return on invested capital (ROIC) is 16.23%.
Return on Equity (ROE) | 32.89% |
Return on Assets (ROA) | 11.42% |
Return on Invested Capital (ROIC) | 16.23% |
Return on Capital Employed (ROCE) | 25.98% |
Revenue Per Employee | 752.64M |
Profits Per Employee | 181.85M |
Employee Count | 75,883 |
Asset Turnover | 0.55 |
Inventory Turnover | 2.24 |
Taxes
In the past 12 months, Novartis AG has paid 2.21 trillion in taxes.
Income Tax | 2.21T |
Effective Tax Rate | 13.80% |
Stock Price Statistics
The stock price has increased by +24.68% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +24.68% |
50-Day Moving Average | 34,268.50 |
200-Day Moving Average | 32,729.75 |
Relative Strength Index (RSI) | 70.27 |
Average Volume (20 Days) | 178 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis AG had revenue of ARS 57.11 trillion and earned 13.80 trillion in profits. Earnings per share was 6,842.86.
Revenue | 57.11T |
Gross Profit | 43.22T |
Operating Income | 19.05T |
Pretax Income | 16.01T |
Net Income | 13.80T |
EBITDA | 23.70T |
EBIT | 19.05T |
Earnings Per Share (EPS) | 6,842.86 |
Balance Sheet
The company has 7.66 trillion in cash and 33.56 trillion in debt, giving a net cash position of -25,897.12 billion.
Cash & Cash Equivalents | 7.66T |
Total Debt | 33.56T |
Net Cash | -25,897.12B |
Net Cash Per Share | n/a |
Equity (Book Value) | 41.26T |
Book Value Per Share | 21,015.03 |
Working Capital | -6,986.95B |
Cash Flow
In the last 12 months, operating cash flow was 20.39 trillion and capital expenditures -1,494.83 billion, giving a free cash flow of 18.89 trillion.
Operating Cash Flow | 20.39T |
Capital Expenditures | -1,494.83B |
Free Cash Flow | 18.89T |
FCF Per Share | n/a |
Margins
Gross margin is 75.68%, with operating and profit margins of 33.35% and 24.16%.
Gross Margin | 75.68% |
Operating Margin | 33.35% |
Pretax Margin | 28.03% |
Profit Margin | 24.16% |
EBITDA Margin | 41.50% |
EBIT Margin | 33.35% |
FCF Margin | 33.08% |
Dividends & Yields
This stock pays an annual dividend of 624.65, which amounts to a dividend yield of 1.61%.
Dividend Per Share | 624.65 |
Dividend Yield | 1.61% |
Dividend Growth (YoY) | 34.57% |
Years of Dividend Growth | 2 |
Payout Ratio | 60.27% |
Buyback Yield | 2.90% |
Shareholder Yield | 4.52% |
Earnings Yield | 4.55% |
FCF Yield | 6.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on October 22, 2020. It was a forward split with a ratio of 2.
Last Split Date | Oct 22, 2020 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Novartis AG has an Altman Z-Score of 3.71 and a Piotroski F-Score of 6.
Altman Z-Score | 3.71 |
Piotroski F-Score | 6 |